Dr Jill Rasmussen
Jill has held senior positions in the Pharma Industry in Europe and the US as well as having experience as a Senior Medical Assessor with the UK regulatory agency the MHRA (formerly the MCA). In 1999 in recognition of her services to CNS research, she was made a Fellow of the Faculty of Pharmaceutical Medicine and in 2012 she was made a Fellow of the Royal College of General Practitioners.
From 2002 to 2004, she was the Director of the UK National Neuroscience Institute.
In addition to her work in psi-napse, Jill continues to work part-time in the National Health Service (NHS) as a primary care specialist in mental health, dementia and learning disability and as Clinical Lead for Dementia in NHS England South Region.
She is a member of major international psychopharmacology and neurology organisations and attends relevant conferences to remain at the cutting edge of both the therapeutic areas and developments in worldwide clinical trial methodology and regulatory strategy.
From 2002 to 2004, Jill was a member of the British Association of Psychopharmacology Council. From 2004 to 2008 she was elected to the Board of the International Psychogeriatric Association (IPA) and served as Treasurer from 2009-2011. She is a founding member of the International Society of CNS Clinical Trials Methodology (ISCTM), where she continues to serve as a member of the Scientific and Finance committees. Jill is Chair of the Lewy Body Society (UK) Specialist Advisory Committee and also a member of Alzheimer’s Association International (AAIC) and of two of their Professional Interest Areas Downs Syndrome and Neuropsychological Symptoms of Dementia.
© psi-napse 1994 - 2024